Neuro-Oncology: The Podcast

Ein Podcast von: Neuro-Oncology

Neuro-Oncology: The Podcast will keep you up to date about the latest advances in the field as we present conversations with the authors of selected papers from Neuro-Oncology and its sister journals, Neuro-Oncology Practice and Neuro-Oncology Advances.

Our American listeners can also listen to Neuro-Oncology: The Podcast at our American site

51 Folgen

Nivolumab in MGMT methylated GBM
Vom 2023-01-27

IDH mutant gliomas; SNO consensus Review
Vom 2023-01-13
DNA methylation subclass and extent of GBM resection
Vom 2022-12-30
Pre-operative [11C]methionine PET for low-grade glioma
Vom 2022-12-16
The role of T lymphocytes in the glioma pathobiology
Vom 2022-12-02
CDKN2A homozygous deletion in IDH mutant astrocytoma
Vom 2022-10-08
EGFR: the lazarus target in glioblastom
Vom 2022-09-23
Brain metastases; a SNO consensus review: Part 2
Vom 2022-09-09
Brain metastases; a SNO consensus review: Part 1
Vom 2022-08-26
Pediatric IDH mutant gliomas
Vom 2022-08-13
Low-risk meningioma: Outcomes from NRG 0539
Vom 2022-07-29
Selumetinib in children with NF1 and plexiform neurofibroma
Vom 2022-07-01
Targeted therapy for BRAF-mutant pediatric glioma
Vom 2022-06-17
Early/evolving IDH wild-type glioblastoma
Vom 2022-05-20
PI3K signaling in IDH mutant gliomas
Vom 2022-05-06
Cell-free DNA from CSF in pediatric, adolescent and young adult patients
Vom 2022-04-22
Molecular determinants of neurocognitive deficits in glioma
Vom 2022-04-08
H3K27M cell-free tumor DNA tracking in response to ONC201 treatment for diffuse midline glioma
Vom 2022-03-25
Clinical trial accrual for women and minorities in neuro-oncology
Vom 2022-03-11
The clinical utility of next generation sequencing for IDHwt glioblastoma
Vom 2022-02-11

51 Folgen

Nivolumab in MGMT methylated GBM

IDH mutant gliomas; SNO consensus Review

DNA methylation subclass and extent of GBM resection

Pre-operative [11C]methionine PET for low-grade glioma

The role of T lymphocytes in the glioma pathobiology

CDKN2A homozygous deletion in IDH mutant astrocytoma

EGFR: the lazarus target in glioblastom

Brain metastases; a SNO consensus review: Part 2

Brain metastases; a SNO consensus review: Part 1

Pediatric IDH mutant gliomas

Low-risk meningioma: Outcomes from NRG 0539

Selumetinib in children with NF1 and plexiform neurofibroma

Targeted therapy for BRAF-mutant pediatric glioma

Early/evolving IDH wild-type glioblastoma

PI3K signaling in IDH mutant gliomas

Cell-free DNA from CSF in pediatric, adolescent and young adult patients

Molecular determinants of neurocognitive deficits in glioma

H3K27M cell-free tumor DNA tracking in response to ONC201 treatment for diffuse midline glioma

Clinical trial accrual for women and minorities in neuro-oncology

The clinical utility of next generation sequencing for IDHwt glioblastoma